Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update

NEXT STORY
Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study
PREV STORY
Spero Therapeutics Receives FDA Fast Track Designation for SPR994 for the treatment of Complicated Urinary Tract infections and Acute Pyelonephritis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting

author_avatar
NASDAQ Market News

Global Digital PCR (dpcr) and Real-Time PCR (qpcr) Market Report 2020-2025 Featuring Prominent Players – Quidel, QIAGEN, Takara Bio, Thermo Fisher Scientific, Bio-Rad, Danaher, F.Hoffmann-La Roche

author_avatar
NASDAQ Market News

Alimera Sciences and Tanner Pharma Group Initiate Global Named Patient Program for ILUVIEN®

author_avatar
NASDAQ Market News